Technology Development for Noninvasive Prenatal Genetic Diagnosis Using Maternal Peripheral Blood
- Study HIC#:2000030949
- Last Updated:02/17/2022
The purpose of this study is to develop a risk-free noninvasive prenatal diagnosis procedure for genetic conditions in the developing fetus by studying fetal cells in maternal blood.
- Age18 years and older
- GenderFemale only
- Start Date01/31/2022
- End Date12/31/2022
Trial Purpose and Description
The purpose of this study is to develop a risk-free noninvasive prenatal diagnosis procedure for genetic conditions in the developing fetus by studying fetal cells in maternal blood.
Eligibility Criteria
Eligibility Criteria:
- >/= 18yo, singleton or twin gestation
- planning to undergo CVS or amniocentesis